X

Anuh Pharma Ltd. Stock Analysis

Small Cap
Evaluated by 666 users | BSE: 506260 | NSE: |
Pharmaceuticals & Drugs
Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.The...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 19.87%22.97%20.12%24.7%24.62%25.26%15.21%10.74%16.01%10.29%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 176226243266284326206238321307
Y-o-Y Gr. Rt.-27.9%7.5%9.8%6.5%15%-36.8%15.5%34.7%-4.3%
Adjusted EPS (Rs.) 2.343.012.83.824.465.483.873.075.043.68
Y-o-Y Gr. Rt.-28.6%-7%36.4%16.8%22.9%-29.4%-20.7%64.2%-27%
Book Value per Share (Rs.) 12.2413.8115.0917.1420.1323.828.0529.8632.8532.37
Adjusted Net Profit 11.715.114.119.222.327.519.415.425.318.5
Net Op. Cash Flow (Rs. Cr.) -0.79.41.614.618.816.526.11.87.148.9
Debt to Cash Flow from Ops -9.640.140.33000.1301.340.620.91
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Anuh Pharma Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 6.4%1.6%14.2%-4.3%
Adjusted EPS 5.2%-3.8%-1.7%-27%
Book Value per Share 11.4104.9-1.5
Share Price 26.8% 2.7% 25.4% 133.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 20.3923.1419.423.7323.9124.9614.9410.6116.0911.29
Operating Profit Margin (%) 9.69.638.3410.4611.9212.311.038.6410.799.96
Net Profit Margin (%) 6.656.695.797.197.878.429.426.477.886.01
Debt to Equity 0.110.020.01000.0200.020.030.27
Working Capital Days 133108111127127116176153139169
Cash Conversion Cycle 14262926293358625438
Entity Percentage Holding
Promoters 72.09%
Non-Institutions 27.90%
Pledged *0.060.050.030.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Anuh Pharma's performance infers:

Anuh Pharma earnings have declined by -3.8%, whereas share price has appreciated 2.7% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Anuh Pharma share prices over the last 10 years. Here is what we found out:

Anuh Pharma share price has appreciated 19.2% annually over the past ten years.

Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.

Anuh Pharma

Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.

Anuh Pharma has a product presence in Africa, Asia, Europe, Central/South America and the Middle East. The company's registered office is at E-17/3 and 17/4 MIDC, Tarapur, Boisar, Thane District 401506

Products

  • Macrolides
  • Higher Macrolides
  • Quinolones
  • Chloramphenicol
  • Anti TB Drug
  • Corticosteroids

Recognitions/Certifications

  • Anuh Pharma has received ‘Star Export House’ certification from the Ministry of Commerce and Industry.
  • The company received WHO-GMP certificate for carrying good manufacturing practices.
  • Anuh Pharma has received  ISO 9001:2000 certification
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback